We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc
ARNA

Delisted

ARNA was delisted on the 10th of March, 2022.

Back to rankings

134 hedge funds and large institutions have $787M invested in Arena Pharmaceuticals Inc in 2013 Q2 according to their latest regulatory filings, with 134 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

15% less call options, than puts

Call options by funds: $68.6M | Put options by funds: $80.9M

Holders
134
Holders Change
+134
Holders Change %
–
% of All Funds
4.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
134
Increased
–
Reduced
–
Closed
–
Calls
$68.6M
Puts
$80.9M
Net Calls
-$12.3M
Net Calls Change
-$12.3M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
TRCT
126
Tower Research Capital (TRC)
New York
$8K +$8.08K +99 New
MFS
127
MSI Financial Services
Massachusetts
$8K +$8.16K +100 New
WA
128
WealthTrust-Arizona
Arizona
$8K +$8.24K +101 New
PVH
129
Psagot Value Holdings
Israel
$3K +$2.69K +33 New
AA
130
Apriem Advisors
California
$2K +$1.63K +20 New
HRIA
131
Haberer Registered Investment Advisor
Ohio
$2K +$1.63K +20 New
JG
132
Jefferies Group
New York
$2K +$2.2K +27 New
WT
133
Whittier Trust
California
$1K +$816 +10 New
GI
134
Gradient Investments
Minnesota
– +$245 +3 New
2 3 4 5
6

ARNA Hedge Fund Activity: Q2 2013 in Review

134 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q2 2013, worth a combined $787M.

Buyers outnumbered sellers: 134 funds opened new ARNA positions and 0 closed out — a net gain of 134 holders — while 0 added to existing stakes and 0 trimmed.

  • 134 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $787M of Arena Pharmaceuticals Inc stock for Q2 2013.
  • 134 funds opened new Arena Pharmaceuticals Inc positions in Q2 2013 and 0 closed out, a net change of +134 holders.

Based on aggregated 13F filings for Q2 2013.